Concepedia

Na Zhou

NZ

14

Publications

606

Citations

13

H-Index

2012

Active since

Affiliations

Guangzhou Medical University(Current)

Shanghai Jiao Tong University

Harvard University

Xuzhou Central Hospital

Brigham and Women's Hospital

Na Zhou is an author at Guangzhou Medical University specializing in medicine, cell biology, and pathology.

ORCID

Top concepts

Publications per year

2012–2023

14

Publications

14

Empagliflozin attenuates cardiac microvascular ischemia/reperfusion injury through improving mitochondrial homeostasis

Rongjun Zou, Wanting Shi, Junxiong Qiu et al. · Cardiovascular Diabetology · 2022 · 117 citations · Full text

SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways

Li Ma, Rongjun Zou, Wanting Shi et al. · Theranostics · 2022 · 109 citations · Full text

MicroRNA-138 inhibits proliferation, migration and invasion through targeting hTERT in cervical cancer

Na Zhou, Dan Fei, Shan Zong et al. · Oncology Letters · 2016 · 49 citations · Full text

Hemoglobin A1c Levels and Aortic Arterial Stiffness: The Cardiometabolic Risk in Chinese (CRC) Study

Jun Liang, Na Zhou, Fei Teng et al. · PLoS ONE · 2012 · 47 citations · Full text

Deubiquitinase OTUD3 regulates metabolism homeostasis in response to nutritional stresses

Na Zhou, Hailong Qi, Junjun Liu et al. · Cell Metabolism · 2022 · 47 citations

, , +10

Rows per page

1–5 of 14